Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ObjectiveTo test the sensitivity of whole-brain T1 relaxometry to the evolution of pathological changes in multiple sclerosis (MS).BackgroundT1-weighted hypointense lesion load in the brains of patients with MS is associated with axonal loss. Other work has shown that T1 measurements may provide information complementary to existing imaging techniques, such as magnetization transfer imaging.MethodsThe authors studied 14 MS patients twice over a median time interval of 19.5 months (range, 14-22 months). Structural images and whole-brain T1 maps using a novel rapid-scanning technique (3 min/study) were performed at 3 T. Analysis focused on defining changes separately in the lesional and normal-appearing white matter (NAWM) and in the cortical gray matter.ResultsAt baseline, there was an inverse relationship between disease duration and the NAWM T1 histogram peak height (r = -0.75, P = .03). The total white matter T1 histogram peak height decreased over time (P < .001). This could be accounted for by changes in the NAWM (P < .03). There also was a decrease (6%) in the mean (11 of 14 patients, P = .004) and in the median (7%) (13 of 14 patients, P < .001) neocortical gray matter T1 over the follow-up period.ConclusionsBrain T1 maps can be generated quickly and are sensitive to pathological changes over time. T1 values in both the gray and the white matter at the baseline visit were related to disease duration, suggesting that the T1 changes are clinically relevant. Although the absolute values will be different, it is likely that similar changes will be able to be detected at 1.5 T. The role of T1 measurement as a magnetic resonance imaging outcome measure in clinical trials now should be explored.

More information Original publication

DOI

10.1111/j.1552-6569.2003.tb00184.x

Type

Journal article

Publication Date

2003-07-01T00:00:00+00:00

Volume

13

Pages

234 - 239

Total pages

5

Addresses

C, e, n, t, r, e, , f, o, r, , F, u, n, c, t, i, o, n, a, l, , M, a, g, n, e, t, i, c, , R, e, s, o, n, a, n, c, e, , I, m, a, g, i, n, g, , o, f, , t, h, e, , B, r, a, i, n, ,, , J, o, h, n, , R, a, d, c, l, i, f, f, e, , H, o, s, p, i, t, a, l, ,, , H, e, a, d, i, n, g, t, o, n, ,, , O, x, f, o, r, d, ,, , U, n, i, t, e, d, , K, i, n, g, d, o, m, .

Keywords

Brain, Cerebral Cortex, Humans, Multiple Sclerosis, Magnetic Resonance Imaging, Analysis of Variance, Sensitivity and Specificity, Time Factors, Adult, Middle Aged, Female, Male